PhilipMorrisInternational (PM) Q3 2025 earnings review
Record EPS Powered by Smoke-Free Growth; Heavy ZYN Investment Hits US Profit
Philip Morris International delivered a record-breaking quarter, with Adjusted Diluted EPS surging 17.3% to $2.24, well ahead of expectations. Growth was driven by the powerful momentum of its smoke-free portfolio (IQOS, ZYN, VEEV), which saw volumes rise 17%. However, the standout story was in the Americas, where a massive promotional campaign to mark ZYN's return to full supply drove a 37% surge in U.S. can shipments but caused the region's adjusted operating income to plummet 44% organically. Despite this significant investment, the company's overall profitability expanded, leading management to raise its full-year EPS guidance, signaling strong confidence in its global strategy.
🐂 Bull Case
All three core smoke-free brands are firing on all cylinders. HTU shipments grew 15.5%, U.S. ZYN shipments rose 37%, and e-vapor (VEEV) volumes jumped 91%, demonstrating successful execution of the multi-category strategy.
The smoke-free business is now structurally more profitable than combustibles, with a gross margin over 70% in Q3. This positive mix shift drove a 1.2 percentage point expansion in the company's overall adjusted operating margin to 43.1%.
Management raised its full-year adjusted diluted EPS forecast to $7.46 - $7.56, implying strong 13.5% to 15.1% growth, signaling confidence in the business trajectory for the remainder of the year despite heavy investments.
🐻 Bear Case
A ~$100 million promotional blitz for ZYN in the U.S. caused a 44% drop in the Americas' adjusted operating income. This raises questions about the long-term cost to acquire and defend market share in this key growth category.
While EPS guidance was raised, the forecast for full-year organic operating income growth was slightly lowered to 10%-11.5% (from 11%-12.5%), indicating the EPS beat is supported by a more favorable tax rate rather than stronger core operations.
Management anticipates a 20-30 million can inventory reduction for ZYN and a reversal of favorable HTU shipment timing in Q4. This will likely create a headwind for reported Q4 volume and revenue growth.
⚖️ Verdict: 🟢
Bullish. The underlying global strength of the smoke-free portfolio is immense and driving significant margin expansion. The heavy investment in ZYN, while causing a sharp one-quarter profit drop in the Americas, is a strategic move to solidify leadership in the fast-growing U.S. market. The raised full-year EPS guidance confirms the core business is more than capable of absorbing these costs and still delivering robust shareholder returns.
Key Themes
The Price of (Re)launch: ZYN Promotions Decimate Americas Profitability
The most significant data point this quarter was the disconnect in the Americas region. While Oral Smoke-Free Product shipments grew 29%, driven by a 37% rise in U.S. ZYN cans, the segment's organic Net Revenues fell 5.0% and Adjusted Operating Income collapsed by 43.5%. Management attributed this to a one-time ~$100 million cost for a 'special September promotion' to 'mark ZYN's return to full availability' and reignite trial among smokers. While successful in driving offtake, it highlights the high cost of competing in the U.S. market and sets a new, lower baseline for regional profitability.
Smoke-Free Portfolio Delivers Broad-Based Strength
PMI's multi-category strategy is executing exceptionally well, with all three key platforms showing strong momentum. Heated Tobacco Unit (HTU) shipments grew 15.5% to 40.8 billion units, driven by strong performance in Europe and Japan. ZYN nicotine pouches saw global can shipments rise 36.4%. The e-vapor brand, VEEV, was a standout, with shipment volumes growing 91%, solidifying its #1 closed-pod position in eight markets. This diversified growth reduces reliance on any single product or market.
Margin Expansion Continues as Smoke-Free Profitability Surpasses Combustibles
The transition to smoke-free products is proving to be a powerful margin driver. In Q3, smoke-free gross margin expanded to 70%, now 3.5 percentage points higher than the combustible business. This accretive mix-shift, combined with scale efficiencies, helped expand the company's total adjusted operating income margin by 1.2 percentage points to a multi-year high of 43.1%. Management is confident this profitability trend will continue.
Combustible Business Remains a Resilient Cash Cow
Despite a 3.2% decline in cigarette shipment volumes, the combustible segment continues to be a powerful financial contributor. Organic net revenues grew 1.0% and organic gross profit grew a robust 4.8%, fueled by high single-digit pricing. Marlboro reached its highest quarterly market share since 2008. This predictable cash flow is critical for funding smoke-free investments and shareholder returns.
Strategic Reorganization Underscores Transformation Progress
PMI announced a major organizational shift effective January 1, 2026. The company will move from four geographic segments to three new business units: International Smoke-Free, International Combustibles, and U.S. This change reflects that the smoke-free business is now operating at a scale that warrants its own distinct international structure, further cementing the company's identity beyond traditional tobacco.
Inventory Adjustments Set Up a Noisy Q4
Management signaled potential headwinds for Q4 reported numbers. They anticipate a 20-30 million can inventory reduction for ZYN in the coming months, which was delayed from Q3. Additionally, favorable HTU shipment timing from H1 is expected to reverse. This suggests Q4 reported volumes could understate true consumer demand, creating a tougher sequential comparison.
Other KPIs
The mix of smoke-free products in PMI's total shipment portfolio continues to grow, reaching 22.9% in Q3 from 19.8% in the prior year quarter. Total volumes grew 0.7% as the 16.6% growth in smoke-free products more than offset the 3.2% decline in cigarettes, demonstrating the success of the portfolio transition.
PMI upgraded its full-year operating cash flow forecast, signaling strong underlying cash generation. The previous forecast was 'approximately $11.5 billion.' This reflects strong profit delivery and reinforces the company's ability to fund investments, deleverage its balance sheet, and support its dividend.
Adjusted in-market sales (IMS), a proxy for consumer demand, grew a robust 9.0% against a tough prior-year comparison. Shipment volume growth of 15.5% was even higher, reflecting what management described as some favorable timing benefits. This out-shipment is expected to reverse in Q4.
Guidance
Accelerating. The company raised its full-year guidance from a prior currency-neutral range that implied $7.33-$7.46. The new midpoint of $7.51 represents a significant 14.3% YoY increase over 2024's $6.57, driven by strong operational performance and a more favorable tax rate outlook.
Decelerating. This metric was revised downward from a previous forecast of 11.0% - 12.5%. The reduction reflects the impact of higher commercial investments, particularly the Q3 ZYN promotions in the U.S. This indicates the EPS guidance raise is being driven by factors below the operating income line.
Stable. The range remains unchanged, but management tempered expectations by guiding to the 'lower half'. This likely reflects the anticipated ZYN inventory de-stock in Q4, but still represents very strong absolute growth for the company's key strategic portfolio.